BioSkryb Genomics

About:

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis.

Website: https://bioskryb.com/

Twitter/X: bioskryb

Top Investors: Anzu Partners, Wilson Sonsini Goodrich & Rosati

Description:

BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis. Through its single cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome, transcriptome, and proteome within a single cell to better understand the drivers, mechanisms, and management of complex disease.

Total Funding Amount:

$31.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)bioskryb.com

Founders:

Charles Gawad, Jay West

Number of Employees:

51-100

Last Funding Date:

2022-03-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai